Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Annikki
Graz, Austriaannikki.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Annikki has developed proprietary cell-free redox biocatalysis platforms enabling the efficient, low-energy production of high-purity chemicals from biomass. Their processes allow clean separation of lignin, cellulose, and hemicellulose from lignocellulosic feedstocks (e.g., straw), supporting sustainable chemical manufacturing with reduced environmental impact[1][2][3].
The company offers technologies under license to produce bio-based chemicals such as FDCA—a key building block for green plastics like PEF and materials used in nylon production[1]. No clinical results are relevant as the company operates in industrial biotechnology rather than healthcare or pharmaceuticals.
- Industry
- Non-Drug Biotech
Beyond the preview
Go deeper on Annikki.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Annikki.